Nasal and sinus inflammation in chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 4, Issue 2, 2007, Pages 163-166

  Kim, Jung Soo ^a,c   Rubin, Bruce K ^b  

^a Kyungpook National University   (South Korea)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

Bronchial hyperresponsiveness; COPD; Macrolide antibiotics; Rhinitis; Sinusitis; Tobacco smoke

Indexed keywords

MACROLIDE;

ASTHMA; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE EXACERBATION; EXPOSURE; HUMAN; INFLAMMATION; LUNG FUNCTION; MOUTH BREATHING; NOSE DISEASE; NOSE OBSTRUCTION; PRIORITY JOURNAL; REVIEW; RHINITIS; SINUSITIS; SMOKING; PATHOPHYSIOLOGY;

HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHINITIS; SINUSITIS; SMOKING;

EID: 34547435238     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550701341228     Document Type: Review

References (31)

1. McCracken GH, Jr. Clinical practice guidelines for the diagnosis and treatment of respiratory tract infections. Am J Managed Care 2001; 7:S183-191.
2. Montnemery P, Svensson C, Adelroth E, Lofdahl C-G, Andersson M, Greiff L, Persson CGA. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J 2001; 17:596-603.
3. Roberts NJ, Lloyd-Own SJ, Rapado F, Patel IS, Wilkinson TMA, Donaldson GC, Wedzicha JA. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respiratory Medicine 2003; 97:909-1004.
4. Nihlen U, Andersson M, Lofdahl CG, Persson CGA, Montnemery P, Greiff L. Nasal neutrophil activity and mucinous secretory responsiveness in COPD. Clin Physiol Funct Imaging 2003;23:38-42.
5. Vachier I, Vignola AM, Chiappara G, Bruno A, Meziane H, Godard P, Bousquet J, Cahnez P. Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax 2004; 59:303-307.
6. Hurst JR, Wilkinson TMA, Perera WR, Donaldson GC, Wedzicha JA. Relationhships among bacteria, upper airway lower airway, and systemic inflammatory in COPD. Chest 2005; 127:1219-1226.
7. Hurst JR, Wilkinson TMA, Donaldson GC, Wedzicha JA. Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD). Respiratory Medicine 2004; 98:767-770.
8. Dewan NA, Rafique S, Kanwar B, Satpathy H, Ryschon K, Tillotson GS, Niederman MS. Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest 2000; 117:662-671.
9. Grossman J. One way, one disease. Chest 1997; 111:11-16S.
10. Togias A. Systemic cross-talk between the lung and the nose. Am J Respir Crit Care Med 2001; 164:726-727.
11. van Manen JG, Bindels PJ, IJzermans CJ, van der Zee JS, Bottema BJ, Schade E. Prevalence of cormobidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001; 54:287-293.
12. Ragab A, Clement P, Vincken W. Objective assessment of lower airway involvement in chronic rhinosinusitis. Am J Rhinol 2004; 18:15-21.
13. Kim J-S, Hackley GH, Okamoto K, Rubin BK. Sputum processing for the evaluation of inflammatory mediators. Pediatr Pulmonol 2001; 32:152-158.
14. Balzano G, Stefanelli F, Iorio C, De Felice A, Melillo E, Martucci M, Melillo G. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med 1999; 160:1486-1492.
15. Henke MO, Shah SA, Rubin BK. The role of airway secretions in COPD - Clinical applications. J COPD 2005; 3:377-390.
16. Okayama M, Iijima H, Shimura S, Shimomura A, Ikeda K, Okayama H, Shirato K. Methacholine bronchial hyperresonsiveness in chronic sinusitis. Respiration 1998; 65:450-457.
17. Hurst JR, Kuchai R, Michael P, Perera WR, Wilkinson TMA, Wedzicha JA. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease. Clin Physiol Funct Imaging 2006; 26:251-256.
18. Brugman SM, Larsen GL, Henson PM, Honor J, Irvin CG. Increased lower airway responsiveness associated with sinusitis in a rabbit model. Am Rev Respir Dis 1993; 147:314-320.
19. Syabbalo NC, Bundgaard A, Entholm P, Schmidt A, Widdicombe, JG. Measurement and regulation of nasal airflow resistance in man. Rhinology 1986; 24:87-101.
20. Annesi-Maesano I, Oryszezyn MP, Neukirch F, Kauffmann F. Relationship of upper airway disease to tobacco smoking and allergic markers: a cohort study of men followed up for 5 years. Int Arch Allergy Immunol 1997; 114:193-201.
21. Turkeltaub PC, Gergen PJ. Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES?). Ann Allergy 1991; 67:147-154.
22. Bascom R, Kesavanathan J, Fitzgerald TK. Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance. Environ Health Perspect 1995; 103:1026-1030.
23. Vinke JG, KleinJan A, Severijnen LWFM, Fokkens WJ. Passive smoking causes an 'allergic' cell infiltrate in the nasal mucosa of subjects with chronic bronchitis. Int J Pediatr Otorhinolaryngol 1999; 51:73-81.
24. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. CD8+ T-lymphocytes in peripheral airway of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:822-826.
25. Wright JL, Lawson LM, Pare PD, Wiggs BJ, Kennedy S, Hogg JC. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 1983; 127:474-477.
26. Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mar TW, Koeter GAH, Timens W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55:12-18.
27. Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173:71-78.
28. Hurst JR, Donaldson GC, Wilkinson TM, Perera WR, Wedzicha JA. Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J. 2005; 26:846-852.
29. Yanagi K Ishii A, Udagawa T, Haruna, Moriyama H. Effects of ESS on sinobronchial syndrome. Nippon Jibbinkoka Gakkai Kaiho 2003; 106:1030-1037.
30. Shinkai M, Park CS, Rubin BK. Immunomodulatory effects of macrolide antibiotics. Clin Pulm Med 2005; 12:341-349.
31. Rubin BK, Henke MO. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest 2004; 125:70S-78S.